Population toxicokinetics of tetrachloroethylene

Area of Science:

• Toxicology
• Pharmacokinetics
• Computational Biology

Background:

• Direct measurement of toxic compound distribution and metabolism in vivo is often infeasible due to ethical or technical constraints.
• Biological systems' complexity and variability present significant challenges for accurate computer modeling.
• Population pharmacokinetics, Bayesian inference, and physiological modeling offer integrated solutions for these challenges.

Purpose of the Study:

• To develop and validate a physiological model for tetrachloroethylene (PERC) distribution and metabolism in humans.
• To estimate the relationship between PERC exposure levels and the fraction of the compound metabolized.
• To inform the derivation of safe exposure limits for PERC.

Main Methods:

• Utilized population pharmacokinetic principles and Bayesian statistical inference.
• Developed a physiological model for PERC distribution and metabolism.
• Derived statistical distributions for model parameters using existing experimental data (Monster et al., 1979).

Main Results:

• The physiological model successfully integrated prior physiological knowledge and experimental data.
• Median estimated fraction of inhaled PERC metabolized was 1.5% at high exposure levels (exceeding occupational standards).
• Median estimated fraction of inhaled PERC metabolized was significantly higher (36%) at low, ambient-like exposure levels (0.001 ppm).

Conclusions:

• A significant disproportionality exists in PERC metabolism relative to exposure levels.
• The findings suggest current safety limits for PERC may not adequately account for metabolic differences at varying concentrations.
• Further experimental verification is recommended to confirm these modeling-based conclusions regarding PERC metabolism.